Literature DB >> 12142645

Pharmacokinetic interaction between high-dose methotrexate and oxacillin.

Karine Titier1, Fabrice Lagrange, Fabienne Péhourcq, Nicholas Moore, Mathieu Molimard.   

Abstract

An 18-year-old man received two high-dose methotrexate cycles for the treatment of an osteosarcoma. Fifteen grams of methotrexate were infused over 6 hours. During the second cycle, co-administration of oxacillin (1g/8h) resulted in prolonged and marked elevation of methotrexate plasma concentrations. The patient experienced acute toxicity with renal failure, myelosuppression, mucitis, fever, and dermatologic abnormalities. After an initial improvement with folinic acid rescue and hemodialysis, the patient died. Oxacillin may thus inhibit the elimination of methotrexate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142645     DOI: 10.1097/00007691-200208000-00018

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  8 in total

1.  Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.

Authors:  O M Escobosa Sánchez; A Herrero Hernández; M J Ortega Acosta; J Camacho Alonso; G Milano Manso; T Acha García
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 3.  Drug interactions in childhood cancer.

Authors:  Cyrine Haidar; Sima Jeha
Journal:  Lancet Oncol       Date:  2010-09-22       Impact factor: 41.316

4.  Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.

Authors:  Hélène Blasco; Delphine Senecal; Amélie Le Gouge; Emmanuelle Pinard; Isabelle Benz-de Bretagne; Philippe Colombat; Jean-Sébastien Hulot; Etienne Chatelut; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

5.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

6.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

7.  Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells.

Authors:  Christina Pfab; Anush Abgaryan; Barbara Danzer; Fatme Mourtada; Weaam Ali; André Gessner; Nahed El-Najjar
Journal:  BMC Cancer       Date:  2022-01-31       Impact factor: 4.430

8.  Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.

Authors:  David Gingrich; Amelia N Deitchman; Amy Kantor; Liusheng Huang; James H Stein; Judith S Currier; Priscilla Y Hsue; Heather J Ribaudo; Francesca T Aweeka
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.